Table 3.

The demographic data and characteristics of AMSAN (1 case) and AMAN (1 case).

Characteristic	Case 1	Case 2
Author (yr)	Farah R(2005)	Kraus J(2007)
Population	Israel	Caucasian
Gender	M	M
Age	71(AMSAN)	65(AMAN)
Preceding factors	+	+
Clinical characteristics	Limb weakness, areflexia, ptosis, dysarthria, dysphagia, respiratory failure	Limb weakness, areflexia, ptosis, dysarthria, dysphagia, respiratory failure
Albumino-cytologic dissociation	+	+
Nerve conduction	+	+
RNS	-	+
Anti-AChR antibody	-	+
Anti-GQ1b antibody	-	+
Edrophonium chloride	-	+
Treatment	plasmapheresis, IVIG	IVIG, corticosteroids, pyridostigmine, azathioprine
Thymectomy	-	-
Prognosis	6	2

M- Male, F - Female, yr - Year, MG - Myasthenia gravis, AMAN - acute motor axonal neuropathy, AMSAN - acute motor-sensory axonal neuropathy, IVIG - intravenous immunoglobulin, RNS - repetitive nerve stimulation. Functional outcome was ranked according to the adopted scale by Hughes: 0, healthy; 1, minor symptoms or signs, able to run; 2, able to walk >5 m without assistance, but unable to run; 3, able to walk >5 m with assistance; 4, bed- or chair-bound; 5, requiring assisted ventilation for at least part of the day; and 6, dead. “+” indicates the patient had precipitating factors from infectious disease.”-” indicates the patient did not have precipitating factors from infectious disease. As for the other parameters, “+” indicates positive findings, and “-” indicates negative findings